Grace color logo (2).jpg
Grace to Participate in Upcoming Investor Conferences
September 06, 2016 16:05 ET | W. R. Grace & Co.
COLUMBIA, Md., Sept. 06, 2016 (GLOBE NEWSWIRE) -- W. R. Grace & Co. (NYSE:GRA) announced today its participation in two upcoming investor conferences. On September 13, 2016, Grace will...
Spring Bank logo.png
Spring Bank Pharmaceuticals Abstracts on STING Agonist SB 11285 Accepted for Poster Presentations at AACR Special Conference on Tumor Immunology and Immunotherapy
September 06, 2016 16:05 ET | Spring Bank Pharmaceuticals Inc.
HOPKINTON, Mass., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (NASDAQ:SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of...
db.png
Dave & Buster’s Entertainment, Inc. Announces Second Quarter 2016 Financial Results
September 06, 2016 16:05 ET | Dave & Buster's Entertainment, Inc.
Achieves Net Income of $21.5 million and EPS of $0.50Affirms Total Revenues, Net Income, and Adjusted EBITDA Guidance for Fiscal 2016 DALLAS, Sept. 06, 2016 (GLOBE NEWSWIRE) --  Dave &...
Peregrine Pharmaceut
Peregrine Pharmaceuticals Declares Quarterly Dividend on Its Series E Convertible Preferred Stock
September 06, 2016 16:05 ET | Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (Nasdaq:PPHM) (Nasdaq:PPHMP) today announced that its Board of Directors has declared a quarterly cash dividend...
Five Prime Therapeut
Five Prime Therapeutics to Present at the Morgan Stanley Global Healthcare Conference
September 06, 2016 16:05 ET | Five Prime Therapeutics, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative...
Prothena_RGB_fullcolor.jpg
Prothena Announces Appointment of Gene G. Kinney as Chief Operating Officer
September 06, 2016 16:05 ET | Prothena Corporation Plc
DUBLIN, Ireland, Sept. 06, 2016 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company focused on the discovery, development, and commercialization...
CDK Global Appoints Eileen Martinson and Steve Schuckenbrock to Its Board of Directors
September 06, 2016 16:05 ET | CDK Global, Inc.
HOFFMAN ESTATES, Ill., Sept. 06, 2016 (GLOBE NEWSWIRE) -- CDK Global, Inc. (Nasdaq:CDK) announced today that its board of directors has appointed two new highly qualified independent directors,...
Blucora Chief Executive Officer to Present at the Goldman Sachs Sixth Annual Financial Technology Conference
September 06, 2016 16:05 ET | Blucora, Inc.
BELLEVUE, Wash., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Blucora, Inc. (NASDAQ:BCOR), today announced that John Clendening, president and chief executive officer, will present at the Goldman Sachs...
RGB-Gradient-Logo-Tag-Horz-R (1).png
Paylocity to Present at the 2016 Deutsche Bank Technology Conference
September 06, 2016 16:05 ET | Paylocity
ARLINGTON HEIGHTS, Ill., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq:PCTY), a cloud-based provider of payroll and human capital management software solutions, today...
Zynerba_Logo-spot_coated_flat_tagline-01.png
Zynerba Pharmaceuticals to Participate in Upcoming Investor Conferences
September 06, 2016 16:05 ET | Zynerba Pharmaceuticals, Inc.
DEVON, Pa., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a specialty pharmaceutical company dedicated to the development of innovative transdermal synthetic...